NT_1170x120_1-11-18

Noninvasive technologies help battle diabetes and NAFLD

Noninvasive technologies help battle diabetes and NAFLD

The American Liver Foundation estimates that over 30% of the U.S. population has some degree of nonalcoholic fatty liver disease (NAFLD), the most common type of liver disease in the Western world. This can impact other facets of their overall health, because NAFLD has been linked to diabetes, obesity, insulin resistance and other metabolic risk